Two-year Outcomes of Remission Induction Therapy with Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis: A Case Series.

Saved in:
Bibliographic Details
Title: Two-year Outcomes of Remission Induction Therapy with Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis: A Case Series.
Authors: Suzuki S; Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Japan., Otani T; Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Japan., Nishi T; Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Japan., Ikeda K; Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Japan., Tamura N; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Japan., Morimoto S; Department of Internal Medicine and Rheumatology, Juntendo University Urayasu Hospital, Japan.
Source: Internal medicine (Tokyo, Japan) [Intern Med] 2026 May 15; Vol. 65 (10), pp. 1416-1420. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Journal Article
Journal Info: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1349-7235
DOI:10.2169/internalmedicine.5825-25